T1D in Film: Why Does Representation Matter?
If you’ve spent any time on social media recently, you’ve likely heard the buzz around the latest Pixar film, Turning…
Top Questions of the Day – December 2021
What we learned from the Online Community in December 2021 Thank you to every member of the T1D Exchange Online…
Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes
T1D Exchange recently had the opportunity to interview Sean Salmon, President of Medtronic Diabetes. In this interview, we discuss Medtronic’s…
An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Community
Meet Dr. A. Enrique Caballero: a Boston-based endocrinologist with decades of experience providing diabetes care to the Latinx community. After…
Connect1d Canada partners with the T1D Exchange
Connect1d Canada, a digital platform that allows those with type 1 diabetes (T1D) to easily learn about and participate in…
Meet the Expert: Increasing CGM Usage and Streamlining Processes
The T1D Exchange Quality Improvement Collaborative (QIC) was established in 2016 — with the support of The Leona M. and…
A Parent’s Guide for Back-to-School with T1D
Life with diabetes can bring a lot of stress, but one of the most stressful events for parents and children…
Everything you need to know about Type 1 Diabetes now in Spanish.
We invite you to explore the new CDC’s type 1 diabetes section, and please share it in English and Spanish…
New T1D Equity Framework Partnership with Medtronic Inc.
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
